The PrEP Access and Coverage Act of 2026 aims to enhance access to pre-exposure prophylaxis (PrEP) medications, crucial for preventing HIV transmission, by making these treatments more affordable and widely available. The legislation seeks to reduce new HIV infections by ensuring that individuals at high risk can obtain PrEP without facing financial barriers. Key provisions include mandates for private health insurance plans to cover PrEP medications and associated services without any cost-sharing.